Through its educational arm, the ISTH Academy, the International Society on Thrombosis and Haemostasis (ISTH) has begun hosting a series of webinars on practical thrombosis and haemostasis issues that scientists and physicians frequently confront. These webinars will allot time for participants to ask questions and will cover the latest information on relevant topics.
Moderated by: Raj Kasthuri
- Description of the available methods for measuring platelet responses
- Relative limitations and advantages of the different methods
- Clinical conditions in which platelet function testing is of proven diagnostic importance
- Emerging areas in which platelet function testing may be of value
- Special problems in platelet function testing
- Area of future clinical research
Genetics of platelet disorders – Neil Morgan
- Types of inherited platelet disorders – reduction in number of platelets or by platelet function defects
- What have we learnt from genetic testing – new and old genes – how identified?
- Genotyping and phenotyping approach
- Next Generation Sequencing technologies – targeted gene sequencing and whole exome sequencing
- The future of genetic testing
- Basic scientists and clinicians interested in platelet function testing and genetics of platelet disorders
- Laboratory technicians involved in the diagnosis of hemorrhagic disorders
- Clinicians interested in platelet function disorders and genetics of platelet function disorders
At the conclusion of this activity, I will be able to:
- Discuss and describe the range of platelet function tests that can be utilized for the study of platelet function in the clinic
- Explain the advantages and limitations of available platelet function tests
- Distinguish the clinical conditions in which platelet function testing can be of help
- Use the rational laboratory diagnostic flow chart for the diagnosis of inherited platelet function disorders
Name | Company | Role |
Chris Ward, MD | Bayer | Advisory Board, Speaker |
Pfizer-BMS | Advisory Board, Speaker | |
Boehringer-Ingelheim | Advisory Board, Speaker | |
Alexion | Advisory Board | |
Medimark | Steering Committee Member, Speaker | |
Raj Kasthuri | Bayer Healthcare, GSK | Consultant |
Geoff Barnes | BMS, Pfizer, Blue Cross Blue Shield of Michigan | Primary Investigator & Co-Investigator |
Yukio Ozaki | Sysmex | Advisory Board |
|
In accordance with the ACCME® Standards for Commercial Support Number 6, all in control of content disclosed any relevant financial relationships. These relationships were reviewed via the MCW conflict of interest resolution process and resolved
Contact
- 1.00 AMA PRA Category 1 Credit(s)™AMA PRA Category 1 Credit(s)™
- 1.00 Hours of ParticipationHours of Participation credit.